Ameriprise Financial filed required documents with the Securities and Exchange Commission on August 16, 2026.
3 reports, 2 independent
Updated Oct 13
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ameriprise Financial filed required documents with the Securities and Exchange Commission on August 16, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ameriprise Financial
financial services company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.
- Multiple major financial firms, including Jane Street, Grayscale Investments, Andreessen Horowitz, and Charles Schwab, submitted comments to the SEC regarding the review of ETFs.
Related events
- Intel filed documents with the SEC on June 6, 2026, indicating regulatory oversight.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.
- A Wealth Management entity filed required reports with the Securities and Exchange Commission on October 22, 2026.
- Medpace filed required documents with the Securities and Exchange Commission on August 15, 2026.
- Novo Nordisk filed required documents with the SEC regarding stock changes on October 22, 2026.